Cargando…
A randomized controlled trial of nebulized surfactant for the treatment of severe COVID-19 in adults (COVSurf trial)
SARS-CoV-2 directly targets alveolar epithelial cells and can lead to surfactant deficiency. Early reports suggested surfactant replacement may be effective in improving outcomes. The aim of the study to assess the feasibility and efficacy of nebulized surfactant in mechanically ventilated COVID-19...
Autores principales: | Dushianthan, Ahilanandan, Clark, Howard W., Brealey, David, Pratt, Danny, Fink, James B., Madsen, Jens, Moyses, Helen, Matthews, Lewis, Hussell, Tracy, Djukanovic, Ratko, Feelisch, Martin, Postle, Anthony D., Grocott, Michael P. W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10684757/ https://www.ncbi.nlm.nih.gov/pubmed/38017061 http://dx.doi.org/10.1038/s41598-023-47672-x |
Ejemplares similares
-
Rapid Phospholipid Turnover after Surfactant Nebulization in Severe COVID-19 Infection: A Randomized Clinical Trial
por: Postle, Anthony D., et al.
Publicado: (2021) -
Nebulised surfactant for the treatment of severe COVID-19 in adults (COV-Surf): A structured summary of a study protocol for a randomized controlled trial
por: Dushianthan, Ahilanandan, et al.
Publicado: (2020) -
Exogenous Surfactant Therapy in Acute Lung Injury/Acute Respiratory Distress Syndrome: The Need for a Revised Paradigm Approach
por: Dushianthan, Ahilanandan, et al.
Publicado: (2012) -
Altered molecular specificity of surfactant phosphatidycholine synthesis in patients with acute respiratory distress syndrome
por: Dushianthan, Ahilanandan, et al.
Publicado: (2014) -
Pulmonary Surfactant in Adult ARDS: Current Perspectives and Future Directions
por: Dushianthan, Ahilanandan, et al.
Publicado: (2023)